These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33254097)

  • 1. Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia.
    Jacobsen DP; Lekva T; Moe K; Fjeldstad HES; Johnsen GM; Sugulle M; Staff AC
    J Reprod Immunol; 2021 Feb; 143():103249. PubMed ID: 33254097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.
    Villa PM; Hämäläinen E; Mäki A; Räikkönen K; Pesonen AK; Taipale P; Kajantie E; Laivuori H
    BMC Pregnancy Childbirth; 2013 May; 13():110. PubMed ID: 23663420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
    He Y; Chen S; Huang H; Chen Q
    J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the expression of human leukocyte antigen G and preeclampsia].
    Zhao SC; Li ZB; He TQ; Yu CZ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):758-62. PubMed ID: 22321350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
    Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
    BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.
    Ngene NC; Moodley J; Naicker T
    PLoS One; 2019; 14(4):e0215807. PubMed ID: 31022243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
    Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
    Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
    Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
    Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?
    Neuman RI; Figaroa AMJ; Nieboer D; Saleh L; Verdonk K; Danser AHJ; Duvekot HJJ; van den Meiracker AH; Roeters van Lennep J; Visser W
    Pregnancy Hypertens; 2021 Mar; 23():116-122. PubMed ID: 33321329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA-G concentrations in obese women during pregnancy and in cord blood.
    Beneventi F; Locatelli E; De Amici M; Martinetti M; Spinillo A
    J Reprod Immunol; 2017 Feb; 119():31-37. PubMed ID: 27984763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
    Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
    J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Arai F; Watanabe T; Kario K; Suzuki M
    Hypertens Res; 2007 Feb; 30(2):151-9. PubMed ID: 17460385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.